| 000 | 05551cam a2200421Ii 4500 | ||
|---|---|---|---|
| 001 | 96599 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112801.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 171012s2017 gw ob 001 0 eng d | ||
| 020 | _a3662471779 | ||
| 020 |
_a3662471787 _q(electronic bk.) |
||
| 020 | _a9783662471777 | ||
| 020 |
_a9783662471784 _q(electronic bk.) |
||
| 020 |
_z9783662471777 _q(print) |
||
| 040 |
_aN$T _beng _erda _epn _cN$T _dGW5XE _dN$T _dOCLCF _dUAB _dDKU _dEBLCP _dAZU _dUPM _dIOG _dCOO _dOCLCQ _dVT2 _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRC776.O3 _b2017 EB |
|
| 245 | 0 | 0 |
_aCOPD : _bheterogeneity and personalized treatment _cSang-Do Lee, editor. |
| 264 | 1 |
_aBerlin, Germany _bSpringer International Publishing _c2017 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF |
||
| 504 | _aIncluye referencias bibliográficas e índice | ||
| 505 | 0 | _a""Preface""; ""Contents""; ""Part I: Overview""; ""1: Definition and Epidemiology of COPD""; "" Definition of COPD""; "" Epidemiology of COPD""; "" Prevalence""; "" Incidence""; "" Mortality""; "" Economic and Social Burden""; ""References""; ""2: Risk Factors: Factors That Influence Disease Development and Progression""; "" Genes""; "" Gender""; "" Lung Growth and Development""; "" Exposure to Particles""; "" Cigarette Smoking""; "" Occupational Exposures to Dusts, Chemical Agents, Fumes""; "" Indoor Air Pollution""; "" Outdoor Air Pollution""; "" Socioeconomic Status"" | |
| 505 | 8 | _a"" Asthma/Bronchial Hyperactivity"""" Infections""; ""References""; ""3: Pathology of Chronic Obstructive Pulmonary Diseases""; "" Introduction""; "" Lung Volumes in Lung Stereology""; "" Normal Lung""; "" Overall Structure""; "" Alveolar Tissue""; "" Small Airways""; "" Lung Cellular Composition""; "" Lung Growth""; "" Aged Lung""; "" COPD""; "" Chronic Bronchitis""; "" Small Airways""; "" Emphysema""; "" Quantification of Emphysema""; "" Microscopic Assessments of Emphysema""; "" Other Forms of Emphysema""; "" Involvement of Cellular Compartments in Emphysema"" | |
| 505 | 8 | _a"" Physiologicalâ#x80;#x93;Pathological Correlations"""" Pulmonary Vascular Structure and Function""; ""References""; ""4: Pathogenesis of COPD""; "" COPD Is an Inflammatory Disease""; "" Inflammatory Cells in COPD""; "" Airway Epithelial Cells""; "" Alveolar Macrophages""; "" Neutrophils""; "" Dendritic Cells""; "" Lymphocytes""; "" Other Cells""; "" Inflammatory Mediators in COPD""; "" Pathogenesis of Emphysema""; "" Protease-Antiprotease Imbalance in the Pathogenesis of COPD""; "" Protease-Antiprotease Imbalance in α1-Antitrypsin Deficiency"" | |
| 505 | 8 | _a"" Protease-Antiprotease Imbalance in COPD Without Antitrypsin Deficiency"""" Oxidative Stress in the Pathogenesis of COPD""; "" Physiological Roles of Radical Species""; "" Oxidative Stress in the Pathogenesis of COPD""; "" Cell Death and Impaired Repair in COPD""; "" Other Pathogenetic Mechanism of Emphysema""; "" Accelerated Aging""; "" Autoimmunity and COPD""; "" Epigenetic Changes in COPD Development""; "" Pathogenesis of Airway Obstruction""; "" Infiltration of Inflammatory Cells in Small Airways""; "" Mucus Hypersecretion""; "" Airway Remodeling"" | |
| 505 | 8 | _a"" Unanswered Question""""References""; ""Part II: Assessment""; ""5: Pathophysiology of COPD""; "" Mucus Hypersecretion and Ciliary Dysfunction""; "" Airflow Obstruction""; "" Hyperinflation""; "" Abnormality of Gas Exchange""; "" Pulmonary Arterial Hypertension""; "" Pathophysiology of COPD Exacerbation""; ""References""; ""6: Diagnosis and Assessment of COPD""; "" Introduction""; "" Diagnosis""; "" Symptoms""; "" Medical History""; "" Physical Examination""; "" Introduction to Pulmonary Function Testing""; "" Spirometry""; "" Lung Volumes"" | |
| 520 | 3 | _aThis book explains how analysis of the heterogeneity of chronic obstructive pulmonary disease (COPD) enhances understanding of the condition and leads to improved, personalized treatment. State of the art knowledge is presented on a range of issues related to the heterogeneity of COPD, such as phenotypes (clinical, physiologic, radiologic, etc.), genotypes, and the tools to be used for dissecting heterogeneity (CT, MRI, biomarkers, etc.). Especially modern radiologic imaging holds promise in this context, and its role is described in detail with the aid of numerous illustrations. The implications of the heterogeneity for personalized treatment are clearly identified, with description of an appropriate tailored treatment strategy for each subgroup of patients. Information is provided on both current and emerging strategies, including bronchoscopic lung volume reduction and approaches to the management of pulmonary hypertension and comorbidities. This book will be a great asset in clinical practice and research for all who have an interest in COPD, a leading cause of morbidity and mortality worldwide. | |
| 650 | 7 |
_aEnfermedad pulmonar obstructiva crónica _2embne _0(OCoLC)fst01003801 _0 _9155837 |
|
| 700 | 1 |
_aLee, Sang-Do, _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-662-47178-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 988 | _aSpringer_Medicine_2017 | ||
| 998 |
_b02/2018 _dz _e- _zSI |
||
| 999 |
_c96599 _d96599 _x1 |
||